Methylnaltrexone prevents morphine-induced kaolin intake in the rat

Life Sciences

Volumn 74, Issue 22, 2004, Pages 2685-2691

  Aung, Han H ^a   Mehendale, Sangeeta R ^a   Xie, Jing Tian ^a   Moss, Jonathan ^a   Yuan, Chun Su ^a,b  

^a UNIVERSITY OF CHICAGO   (United States)

^b UNIVERSITY OF CHICAGO   (United States)

Author keywords

Emesis; Kaolin; Morphine; Nausea and vomiting; Opioid; Pica:Methylnaltrexone

Indexed keywords

17 METHYLNALTREXONE; KAOLIN; MORPHINE; ONDANSETRON;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BODY WEIGHT; CATALEPSY; CONTROLLED STUDY; DOSE RESPONSE; FOOD INTAKE; INGESTION; LOCOMOTION; MALE; NONHUMAN; PICA; RAT; RESPIRATORY DISTRESS; STATISTICAL SIGNIFICANCE; VOMITING;

ANIMALS; ANTIEMETICS; DIET; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG THERAPY, COMBINATION; INJECTIONS, INTRAPERITONEAL; KAOLIN; MALE; MORPHINE; NALTREXONE; NARCOTIC ANTAGONISTS; ONDANSETRON; PICA; QUATERNARY AMMONIUM COMPOUNDS; RATS; RATS, WISTAR;

ANIMALIA; EMESIS; PICA;

EID: 1642343651     PISSN: 00243205     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.lfs.2003.08.047     Document Type: Article

References (25)

1. Aung H.H., Dey L., Mehendale S., Xie J.T., Wu J.A., Yuan C.S. Scutellaria baicalensis extract decreases cisplatin-induced pica in rats. Cancer Chemotherapy and Pharmacology. 52:2003;453-458.
2. Borison H.L., Wang S.C. Physiology and pharmacology of vomiting. Pharmacological Reviews. 5:1953;193-230.
3. Brown D.R., Goldberg L.I. The use of quaternary narcotic antagonists in opiate research. Neuropharmacology. 24:1985;181-191.
4. Costello D.J., Borison H.L. Naloxone antagonizes narcotic self-blockade of emesis in the cat. Journal of Pharmacology and Experimental Therapeutics. 203:1977;222-230.
5. Cubeddu L.X. Serotonin mechanisms in chemotherapy-induced emesis in cancer patients. Oncology. 53(Suppl. 1):1996;18-25.
6. Davies P.R., Warwick P., O'Connor M. Antiemetic efficacy of ondansetron with patient-controlled analgesia. Anaesthesia. 51:1996;880-882.
7. Foss J.F., Bass A.S., Goldberg L.I. Dose-related antagonism of the emetic effect of morphine by methylnaltrexone in dogs. Journal of Clinical Pharmacology. 33:1993;747-751.
8. Gmerek D.E., Cowan A., Woods J.H. Independent central and peripheral mediation of morphine-induced inhibition of gastrointestinal transit in rats. Journal of Pharmacology and Experimental Therapeutics. 236:1986;8-13.
9. Kotake A.N., Kuwahara S.K., Burton E., McCoy C.E., Goldberg L.I. Variations in demethylation of N-methylnaltrexone in mice, rats, dogs, and humans. Xenobiotica. 19:1989;1247-1254.
10. Mitchell D., Wells C., Hoch N., Lind K., Woods S.C., Mitchell L.K. Poison induced pica in rats. Physiology and Behavior. 17:1976;691-697.
11. Mitchell D., Krusemark M.L., Hafner E. Pica: A species relevant behavioral assay of motion sickness in the rat. Physiology and Behavior. 18:1977;125-130.
12. Murphy D.B., Sutton J.A., Prescott L.F., Murphy M.B. Opioid-induced delay in gastric emptying: a peripheral mechanism in humans. Anesthesiology. 87:1997;765-770.
13. Takeda N., Hasegawa S., Morita M., Matsunaga T. Pica in rats is analogous to emesis: an animal model in emesis research. Pharmacology Biochemistry and Behavior. 45:1993;817-821.
14. Takeda N., Hasegawa S., Morita M., Horii A., Uno A., Yamatodani A., Matsunaga T. Neuropharmacological mechanisms of emesis I. Effects of antiemetic drugs on motion- and apomorphine-induced pica in rats. Methods and Findings in Experimental and Clinical Pharmacology. 17:1995;589-590.
15. Takeda N., Hasegawa S., Morita M., Horii A., Uno A., Yamatodani A., Matsunaga T. Neuropharmacological mechanisms of emesis II. Effects of antiemetic drugs on cisplatin-induced pica in rats. Methods and Findings in Experimental and Clinical Pharmacology. 17:1995;647-652.
16. Tsukamoto G., Adachi A. Neural responses of rat area postrema to stimuli producing nausea. Journal of the Autonomic Nervous System. 49:1994;55-60.
17. Wilson C.W.M., Brodie B.B. The absence of blood-brain barrier from certain areas of the central nervous system. Journal of Pharmacology and Experimental Therapeutics. 133:1961;332-334.
18. Wilson C.W.M., Murray A.W., Titus E. The effects of reserpine on uptake of epinephrine in brain and certain areas outside the blood-brain barrier. Journal of Pharmacology and Experimental Therapeutics. 135:1962;11-16.
19. Yuan C.S., Barber W.D. Area postrema: gastric vagal input from proximal stomach and interactions with nucleus tractus solitarius in cat. Brain Research Bulletin. 30:1993;119-125.
20. Yuan C.S., Foss J.F. Gastric effects of methylnaltrexone on mu, kappa, and delta opioid agonists induced brainstem unitary responses. Neuropharmacology. 38:1999;425-432.
21. Yuan C.S., Foss J.F. Methylnaltrexone: Investigation of clinical applications. Drug Development Research. 50:2000;133-141.
22. Yuan C.S., Foss J.F., Moss J. Effects of methylnaltrexone on morphine-induced inhibition of contraction in isolated guinea-pig ileum and human intestine. European Journal of Pharmacology. 276:1995;107-111.
23. Yuan C.S., Foss J.F., O'Connor M., Toledano A., Roizen M.F., Moss J. Methylnaltrexone prevents morphine-induced delay in oral-cecal transit time without affecting analgesia: A double-blind randomized placebo-controlled trial. Clinical Pharmacology and Therapeutics. 59:1996;469-475.
24. Yuan C.S., Foss J.F., Osinski J., Roizen M.F., Moss J. Efficacy of orally administered methylnaltrexone in decreasing subjective effects after intravenous morphine. Drug and Alcohol Dependence. 52:1998;161-165.
25. Yuan C.S., Foss J.F., O'Connor M., Osinski J., Karrison T., Moss J., Roizen M.F. Methylnaltrexone for reversal of constipation due to chronic methadone use: A randomized, controlled trial. JAMA. 283:2000;367-372.